sequencing parp inhibitors in advanced ovarian cancer
Published 5 years ago • 182 plays • Length 6:43Download video MP4
Download video MP3
Similar videos
-
3:23
sequencing antiangiogenic agents in advanced ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:22
dr. penson on the eligibility criteria for parp inhibitors in advanced ovarian cancer
-
0:58
dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
9:39
parp inhibitor selection in ovarian cancer
-
6:44
parp inhibitors in advanced ovarian cancer
-
5:34
differences among parp inhibitors in ovarian cancer
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
4:40
solo-1 and parp inhibitors in ovarian cancer
-
6:53
treatment sequencing in advanced ovarian cancer
-
2:02
dr. konecny on resistance to parp inhibitors in ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
-
8:15
sequencing therapies in ovarian cancer
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
5:53
adverse-effect profiles of parp inhibitors in ovarian cancer
-
0:50
dr. secord on the role of parp inhibitors in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
6:51
platinum sensitivity and parp inhibition in ovarian cancer